Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients

NCT06690970 is registered in ClinicalTrials.gov with Tianjin Medical University as lead sponsor.

NCT NCT06690970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06690970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients
Lead sponsor
Tianjin Medical University
Phase
Observational
Overall status
Recruiting
Start date
September 1, 2020
Completion date
December 1, 2027
Enrollment
500 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

fap, hepatic cancer, metastasis, positron emission tomography, prostate cancer, psma-related disease